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Women who have had premenopausal total hysterectomy at a young age could probably experience partial or total loss of 
ovarian function. The purpose of this retrospective cross-sectional study is to investigate the ovarian function in women 
underwent hysterectomy at an early age. A total of 1165 subjects comprised of 685 hysterectomised women and 480 age 
matched controls were enrolled in the study. We found that there is a steady decline in serum Anti Mullerian Hormone 
(AMH) levels, a marker of ovarian function after every five years post - hysterectomy in early age groups (20-30 years and  
31-40 years) followed by loss of ovarian function in the age group of 40-50 years. The application of multiple linear 
regression and machine learning tools has revealed that AMH is positively correlated with LH and estradiol and negatively 
correlated with age, FSH, years since hysterectomy and vitamin D. Serum AMH level of <0.08 ng/mL is associated with the 
increased of FSH, decreased LH and estradiol. The decreased ovarian function is associated with lower calcium levels, 
which are likely to influence the bone health. In conclusion, by utilizing multiple linear regression and machine learning 
tools, we found that serum FSH is the most important in predicting the AMH-mediated ovarian function. 
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Hysterectomy is a procedure for surgical removal  
of uterus, one of the common gynecologic procedures  
in medical practice. Hysterectomy before natural 
menopause, is one of the major gynecological procedures 
in reproductive-age women, the hysterectomy rate 
increases as women get older and peaks between the  
40 and 50 years for benign gynecological indications 
mainly uterine leiomyoma’s, dysfunctional uterine 
bleeding and endometriosis to improve the quality  
of life
1,2
. Hysterectomy with oophorectomy in 
premenopausal women results in an abrupt hormonal 
imbalance, sudden onset of menopausal symptoms and 
may lead to cardiovascular risk, neurodegenerative 
disease and osteoporosis
3-9
. 
In 2003, over 600000 hysterectomies were performed 
in the United States alone, of which over 90% were 
performed for benign conditions
10
. The analysis  
from UK suggest a hysterectomy rate of 42/100000 
population, Canada (108/100000), whereas in 
Germany reporting rates of 236/100000 and Australia 
165/100000
11,12
. Hysterectomy rates in women aged 
25 years and over have declined in the first decade of 
the 21
st
 century. However, in the last 5 years, the rates 
appear to have stabilized
12-14
.  
Unlike developed countries, many Indian rural 
women undergo hysterectomy with or without 
oophorectomy before 40 years of age for benign 
gynecological complaints thus experience the early 
onset of menopause symptoms compared to non-
hysterectomised women. The National Family Health 
Survey‐4 in India provided the first nationally 
representative estimates of hysterectomy among the 
women aged 15–49 years. The prevalence estimates 
were highest in four states, where the proportion  
of hysterectomy cases among the women aged  
40–49 years was: Andhra Pradesh (22.4%), Bihar 
(14.5%), Gujarat (12.6%), and Telangana (20.1%). 
Almost one‐half (46.1%; 95% CI 44.8–47.5) of 
women who reported having undergone hysterectomy 
had already been previously sterilized, as reported for 
contraception use
15
. 
—————— 
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MLR, multiple linear regression; TGL, triglycerides; WC, waist 
circumference; YSH, years after hysterectomy 
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In our preliminary study, we found that women 
with poor socioeconomic status and less literacy are 
preferring hysterectomy as final remedy for benign 
gynecological complaints instead of other alternate 
medical treatment
16
. Till now, very limited data is 
available on premenopausal hysterectomy associated 
effects on ovarian function and health outcome
17-19
. 
Studies have shown that the determination of serum 
AMH levels is the direct predictor of menopause and 
ovarian function
20,21
. In a study, it was demonstrated 
that the serum AMH levels of < 0.2 ng/mL occur on 
average 5.99 years preceding to menopause in women 
aged 45-48 years and 9.94 years in women aged  
35-39 years
22
. Hence a retrospective cross-sectional 
study was carried out in women with premenopausal 
hysterectomy to assess the serum AMH levels, a 
marker of ovarian function. 
 
Materials and Methods 
The retrospective cross-sectional study was conducted 
on hysterectomised women from October 2015 to June 
2018 to assess the impact of premenopausal hysterectomy 
on ovarian function and associated health related 
consequences. This study was approved by Institutional 
Ethics Committee (IEC), Nizam’s Institute of Medical 
Sciences (EC/NIMS/1478/2014), Hyderabad, India 
 
Hysterectomy Group 
Women who have undergone hysterectomy for benign 
gynecological indications. 
 
Control Group 
Age-matched women with intact reproductive organs 
were considered as control Subjects. 
 
Inclusive criteria 
Women, who had completed the family, undergone 
bilateral tubal sterilization and non-smokers with no 
history of any type of cancer, were included as the cases. 
 
Exclusion criteria 
Women with type 2 diabetes mellitus, hypothyroidism, 
past history of cancer followed by radiation/ 
chemotherapy and debilitating illness etc. 
A total of 1165 women were enrolled into this study. 
Hysterectomised women were recruited through field 
survey in rural areas of Nalgonda and Yadadri districts 
of Telangana state, India by snowball technique and 
age-matched control subjects were enrolled from their 
neighbour houses or associates in same geographical 
area. Blood samples from control subjects were 
collected on day 2 - 4 of their menstrual cycle.  
All the participants were interviewed with the 
support of female health worker (Like Asha 
worker/village level volunteers) and informed consent 
was obtained prior to enrolment. As part of study, 
participants’ demographic information was collected 
with the help of IEC approved questionnaire. From 
each participant, 8 mL of fasting blood sample was 
collected for assessing biochemical parameters (i.e. 
fasting blood glucose, total cholesterol, HDL 
cholesterol, triglycerides, calcium and hemoglobin) 
and hormones (i.e. FSH, LH, TSH, estradiol and 
AMH). Following centrifugation at 3000 × g for  
15 min, serum samples were separated and two aliquots 
of the serum were stored at −80°C for hormones,  
25-OH-Vitamin D3 and MDA (malondialdehyde) 
estimations. All other biochemical and hematological 
investigations were performed on the same day as per 
the standard protocols. 
Blood hemoglobin level was estimated by 
spectrophotometric Drabkin’s method and fasting 
glucose, lipid profile and serum calcium were 
estimated by using Roche C411 fully automated 
chemistry analyzer. Follicle stimulating hormone 
(FSH), luteinizing hormone (LH), estradiol and 
thyroid stimulating hormone (TSH) levels estimated 
were by using commercially available kit (Cal Bio 
ELISA kit), whereas anti mullerian hormone (AMH) 
levels were estimated by using ELISA kit (Ansh Labs, 
USA). 
Serum 25-hydroxy vitamin D3 (25-OH Vit D3) 
levels were estimated by high performance liquid 
chromatography (HPLC) as per the protocol of 
Galunska BT et al.
23
. Serum malondialdehyde level 
was determined by HPLC as per the protocol of  
Ana-Marija Domijan et al.
24
 and reconfirmed by 
TBARS spectrophotometric method
25
. 
 
Statistical analysis 
Student t-test was performed to assess whether the 
mean difference between the two given groups is 
statistically significant. Analysis of variance 
(ANOVA) was used if there were more than two 
groups. Fisher exact test was used to calculate odds 
ratio (OR) and 95% confidence interval (CI) based on 
the distribution of categorical variable in two groups. 
Multiple linear regression (MLR) equation was 
deduced by applying the y = m1x1 + m2x2 + 
…………+mnxn + C formula where in ‘y’ represents a 
dependent variable (outcome variable) and 
‘x1,x2,…,xn’ represent independent variables likely to 
influence the dependent variable (input variables). 
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The values of m1, m2, ...….., mn represent the 
contribution of each variables towards the outcome. 
In order to delineate very complex inter-relationships, 
we have used machine learning based-association 
rules, which were based on ‘IF’ and ‘THEN’ rules26. 
The confidence, support and leverage were used as 
performance indicators for these association rules. 
Further, each of these rules was cross-verified based 
on Fisher exact test for accuracy, sensitivity, 
specificity apart from determining the odds ratio and 
95% confidence interval. 
 
Results 
As shown in (Table 1), the demographic details of 
the study groups were collected. No statistically 
significant difference was observed between the 
hysterectomy with or without ovarian function in 
terms of age, body mass index (BMI), waist 
circumference (WC), and age at hysterectomy. The 
percentage of women with premenopausal 
hysterectomy without ovarian function was high in 
the age group of 31-35 years and 36-40 years 
compared to premenopausal hysterectomy with 
ovarian function (Table 1). 
As depicted in (Table 2), AMH levels were used as 
markers of ovarian function with AMH below 
detection limit as ovaries without function and 
categorized as hysterectomy without ovarian function. 
Serum FSH and LH levels were elevated and estradiol 
levels were low in hysterectomy group without 
ovarian function (Table 2). Serum vitamin D3 levels 
were found to be low in hysterectomy group as 
compared to control. In addition, we found increased 
oxidative stress in hysterectomy groups in particularly 
pre-menopausal hysterectomy group as compared to 
control.  
There was a significant and steady decline in serum 
AMH and vitamin D levels in patients with increasing 
years after hysterectomy (Table 3). 
As shown in (Fig. 1), the post-hysterectomy duration 
influence on ovarian function in pre-menopausal 
women was assessed. When compared to controls, there 
is a steady decline in ovarian function after every  
five years post - hysterectomy in early age groups  
(20-30 years  and  31-40  years) followed  by  loss  of 
ovarian function in the age group of 40-50 years. 
Hence, pre-menopausal hysterectomy accelerates the 
early menopause. AMH is positively correlated with  
 
Table 1 — Demographic details of the studied subjects 
Parameter 
Premenopausal Group Post-Menopausal Group 
Control 
Hysterectomy with 
ovarian function 
Hysterectomy without 
ovarian function 
Control Hysterectomy 
Demographic Information 
No. of Cases 301 380 131 179 174 
Age (years)  31.7 ± 5.5 34.6 ± 4.9 34.5 ± 4.1 50.8 ± 3.5 51.4 ± 3.3 
BMI (Kg/m2) 23.2 ± 4.8 23.1 ± 4.4 22.8 ± 3.8 23.9 ± 5.4 23.5 ± 4.7 
WC (cm)  79  ± 8.3     81 ± 10.2   84 ± 9.5  78 ± 9.8     83 ± 10.4 
Age at Hysterectomy 
<20 Years. -- 4(1.1%) 0(0%) -- 0(0%) 
20 - 25 Years. -- 148(38.9%) 46(35.1%) -- 1(0.6%) 
26 - 30 Years. -- 164(43.2%) 53(40.5%) -- 2(1.1%) 
31 - 35 Years. -- 47(12.4%) 23(17.6%) -- 7(4.0%) 
36 – 40 Years. -- 17(4.5%) 9(6.9%) -- 29(16.7%) 
41-45 Years. -- 0(0%) 0(0%) -- 86(49.4%) 
>45 Years. -- 0(0%) 0(0%) -- 49(28.2%) 
Level of Education 
No Schooling 187(62.3%) 203(53.4%) 87(66.4%) 124(69.3%) 139(79.9%) 
Primary Schooling 48(16%) 126(33.2%) 28(21.4%) 37(20.7%) 16(9.2%) 
Secondary School 56(18.7%) 43(11.3%) 14(10.7%) 13(7.3%) 14(8.0%) 
Higher education 9(3%) 8(2.1%) 2(1.5%) 5(2.8%) 5(2.9% 
Place of Surgery 
Govt Hospitals -- 78(20.5%) 21(16.2%) -- 42(24.1%) 
Insurance Hospital -- 13(3.4%) 2(1.5%) -- 13(7.5%) 
Private Hospital -- 289(76.1%) 107(82.3%) -- 119(68.4%) 
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Table 2 — Biochemical parameters of premenopausal group were compared with respective age matched control group 
Parameter Hysterectomy  
(N =380) (a) 
Hysterectomy without ovaries function 
(N =131 ) (b) 
Control 
(N=301) (c) 
P-value 
Hemoglobin (g/dL) 11.7 ± 1.8 11.9 ± 1.3 11.8 ± 1.2 a - 0.314 
b - 0.8113 
Glucose (mg/dL) 90 ± 24.5 94 ± 24.3 89 ± 20.0 a - 0.6766 
b – 0.0211* 
Total Cholesterol (mg/dL) 135 ± 41.9 138 ± 40.5 138 ± 39.8 a - 0.4242 
b - 0.9808 
HDL Cholesterol (mg/dL) 35.8 ± 7.6 37.9 ± 6.4 37.0 ± 6.4 a - 0.0269* 
b - 0.1575 
Calcium (mg/dL) 8.8 ± 1.6 8.3 ± 0.8 8.9 ± 1.2 a - 0.0638 
b - 0.2879 
AMH (ng/mL) 1.57 ± 1.90 BLD 2.63 ± 1.93 a - < 0.0001* 
FSH (mIU/mL) 9.9±8.5 69.6±20.8 14.4±9.8 a - < 0.0001* 
b - <0.0001* 
LH (mIU/mL) 16.4 ±16.8 46.4 ±18.7 23.9 ±20.5 a - < 0.0001* 
b - <0.0001* 
Estradiol (pg/mL) 45.3 ± 36.4 15.3 ± 17.4 86.4 ± 67.6 a - < 0.0001* 
b - < 0.0001* 
25-OH Vitamin D3 (ng/mL) 23.83±12.67 23.95±12.42 28.21±19.55 a - 0.0004* 
b - 0.0213* 
MDA (nmol/mL) 7.676±4.486 9.057±5.731 4.123±3.313 a - < 0.0001* 
b - < 0.0001* 
HDL, high density lipoprotein; AMH, anti-müllerian hormone, FSH, follicle stimulating hormone; LH, Luteinizing hormone; MDA, 
malondialdehyde; BLD, below limit of detection. 
P <0.05 was considered as significant 
 
Table 3 — Serum AMH and Vitamin D levels in patients with different years of hysterectomy 
Cases AGE (years) No. of cases AMH (ng/mL) Vitamin - D (ng/mL) 
Controls  31.7 ± 5.5 301 2.63 ± 1.93 28.21 ± 19.55 
YSH (1-2 Years.) 32.7 ± 3.6 56 1.94± 1.53* 25.3 ± 16.2 
YSH (3-4 Years.) 33 ± 3.5 67 1.76 ± 1.54** 25.0 ± 14.5 
YSH (5-6 Years.) 34 ± 3.7 79 1.66 ± 1.7** 24.0 ± 11 
YSH (7-8 Years.) 36 ± 2.7 94 1.01± 0.96** 24.0 ± 12.9* 
YSH (9-10 Years.) 37 ± 3.5 84 0.82 ± 0.54** 22.3 ± 8.1# 
YSH, years of hysterectomy, *P <0.05 , **P <0.001, #P <0.005 vs control 
 
 
 
Fig. 1 — Ovarian function depletion in early hysterectomy 
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Fig. 2 — Factors influencing the ovarian function 
 
LH and estradiol (E2); and negatively correlated with 
age, FSH, years since hysterectomy and vitamin D 
(Fig. 2). 
The association statistics followed by Fisher exact 
test revealed that AMH level <0.08 ng/mL is 
associated with FSH>49.65 mIU/mL (OR: 1519.18, 
95% CI: 470.76 – 4902.48), LH<23.1 mIU/mL (OR: 
44.84, 95% CI: 28.02 – 71.76), E2<11.6 pg/mL (OR: 
5.62, 95% CI: 3.94 – 8.05) and calcium between 
7.795-8.53 mg/dl (OR: 1.59, 95% CI: 1.24 – 2.05). 
We found serum FSH is the most important predictor 
with 94.9% accuracy, 87% sensitivity, 99.6% 
specificity in predicting the AMH-mediated ovarian 
function. LH has 80.1% accuracy in predicting 
ovarian function with 94.8% sensitivity and 71.3% 
specificity. Estradiol has 69.6% accuracy in 
predicting ovarian function with less sensitivity 
(31.3%) and high specificity (92.5%). The decreased 
ovarian function is associated with lower calcium 
levels, which are likely to influence the bone health. 
Excluding FSH and LH from the prediction, a 
multiple linear regression equation was deduced to 
assess the influence of other variables (independent 
variables) such as age, BMI, waist circumference 
(WC), hemoglobin (Hb), glucose, cholesterol 
(CHOL), HDL-cholesterol, triglycerides (TGL), years 
of hysterectomy (YSH) and vitamin D on AMH 
(dependent variable), a marker of ovarian function.  
 
Multiple Linear Regression: 
AMH (ng/mL) = 5.8360942276588 – 
(0.114063339325046 * Age) + (0.0037324282459407 
*BMI) – (0.00158220222787886*WC) + 
(0.000221113584605223*Hb) – 
(0.00485909394522061*Glucose) + 
(0.00354554505347972*CHOL) – 
(0.00586280707338296*HDL CHOL) – 
(0.00249557097326928*TGL) + 
(0.0287730722074681*Calcium) + 
(0.00364417158738729*Estradiol) – 
(0.93735670504571*Surgery Status) + 
(0.0093524909625016*YSH) + 
(0.00404664453819367*Vitamin D) 
 
This equation clearly demonstrates that 
hysterectomy decreases AMH levels by 0.94 ng/mL. 
Age specific decrease in AMH was evident with 1.14 
ng/mL decrease per decade of life. Calcium levels 
were positively associated with AMH levels. 
Contribution of other factors towards AMH is not 
statistically significant. Overall, this equation could 
explain 32.7% variability in AMH levels. 
 
Discussion 
The current study investigated the effect of  
pre-menopausal hysterectomy on ovarian function 
following 5 years and 10 years post-hysterectomy 
period. The results depicted a gradual decline in the 
ovarian function thus inducing early menopause in the 
hysterectomy group. Earlier, Abdelzim et al., reported 
no evidence of ovarian dysfunction till 12 months of 
hysterectomy in premenopausal women
17
. Similar 
observation was also reported in a recent study with  
3 months follow up data after salpingectomy with no 
difference in AMH levels following surgery
27
. These 
studies put together point towards the slow depletion of 
ovarian function over a period of 5 years or 10 years 
duration following surgery but not immediately. 
The current study demonstrated lower calcium 
levels in women with loss of ovarian function (AMH 
<0.08 ng/mL), which corroborates with a recent study 
that demonstrated an inverse association of annual 
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rate of AMH decline with intake of dairy products, 
milk, total calcium and dairy calcium
28
. The free 
estradiol levels were found to decrease in 
premenopaual women following hysterectomy, which 
is consistent with a recent study
29
. The association 
between the oxidative stress and estrogen deficiency 
has been confirmed in several human studies
30-32
. In a 
study, increased oxidative stress was observed in 
postmenopausal women showing elevated levels of 
serum MDA and oxidized lipoproteins as compared to 
fertile women
31
. In another study, elevated levels of 
serum MDA and decreased levels of serum GSH 
levels were observed in postmenopausal women as 
compared to the premenopausal women group
32
. The 
results of the current study corroborated with study by 
Bellanti et al., in demonstrating reduction of estradiol 
levels and increased oxidative stress following 
premenopausal hysterectomy
33
. In addition, we also 
found that the higher levels of MDA in 
premenopausal hysterectomy with the decline in the 
ovarian function as compared to normal ovarian 
function indicating oxidative stress do contribute to 
ovarian dysfunction in women under premenopausal 
hysterectomy. 
The current study is the first of its kind to employ 
machine learning tools to understand premenopausal 
hysterectomy influence on the ovarian function and 
bone metabolic markers. Thresholds of the prime 
determinants i.e. FSH, LH, estradiol, calcium were 
established with reference to AMH threshold that 
distinguishes women with ovarian function with those 
without ovarian function. This is further substantiated 
by Fisher exact test to validate each association in 
terms of overall accuracy, sensitivity and specificity. 
This data is consistent with a recent study from China 
that demonstrated decrease in AMH and increase in 
FSH after hysterectomy with more severe effect in 
younger patients
34
. 
A recent study explored the relation of AMH and 
antral follicle count with cardiometabolic parameters
35
. 
Consistent with this study, we observed the high waist 
circumference in premenopausal hysterectomy women 
with loss of ovarian function. Consistent with the 
current study, lower levels of AMH were reported in 
women with overt hypothyroidism
36
. 
The major strengths of the current study are: (i) its 
sample size; and (ii) application of multiple linear 
regression, machine learning, Fisher exact analysis to 
establish the inter-relationships of AMH with FSH, 
LH, E2 and calcium in premenopausal hysterectomy. 
The limitations are (i) lack of information on the 
nutritional status of the participants; (ii) other life 
style risk factors could not be considered in the 
prediction models. Future studies are warranted to 
investigate these parameters for a better understanding 
of ovarian function alterations in the post-hysterectomy 
periods, specifically by considering efficacy of hormonal 
therapy in restoring ovarian reserves. 
 
Conclusion 
Pre-menopausal hysterectomy show a slow decline 
in AMH levels probably may have impact on ovarian 
function after every five years post - hysterectomy in 
early age groups (20-30 years and 31-40 years) 
followed by loss of ovarian function in the age group 
of 40-50 years. By utilizing multiple linear regression 
and machine learning tools and observed that serum 
FSH is the most important in predicting the AMH-
mediated ovarian function with greater rate of 
accuracy, sensitivity and specificity. Non-hormonal 
factors contribute to 32.7% AMH levels.  
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